Topic: research and development
Eli Lilly is combining the oncology team at Lilly Research Laboratories with Loxo Oncology and putting a trio of Loxo execs at the helm.
AstraZeneca wants its growing Chinese team to take global leadership on some projects for the first time.
Most top R&D executives from across biopharma are earning around $7 million a year.
10. Jay Bradner, Novartis
9. Hal Barron, GlaxoSmithKline
8. Roger Perlmutter, Merck & Co.
7. Thomas Lynch, Bristol-Myers Squibb
5. Mikael Dolsten, Pfizer
4. John McHutchison, Gilead Sciences
3. Michael Severino, AbbVie